Sanofi

Researchers call on Pfizer to delay COVID-19 vaccine application

The pledge was also co-signed by the CEOs of AstraZeneca, Johnson &Johnson, Merck, Moderna and Novavax, as well as Sanofi and GlaxoSmithKline.

EU will shoulder certain liability costs in AZ COVID-19 vaccine deal

The EU has also signed a deal with Sanofi for access to its GlaxoSmithKline-partnered COVID-19 vaccine, although a similar liability clause has not been added to this agreement. ... This could be due to the higher price sought by Sanofi for its vaccine,

Could formulary intelligence be your brand differentiator?

Toujeo – a long-acting insulin injection (diabetes) and heir to Sanofi’s #1 insulin brand Lantus.

Lilly’s Olumiant combined with Gilead’s remdesivir hits the mark in COVID-19

This includes Sanofi’s Kevzara (sarilumab) and Roche’s Actemra (tocilizumab), although both of these drugs failed their respective studies in COVID-19. ... Despite the disappointing results, Roche is continuing its investigation of Actemra in severe

Sanofi, GSK to launch human trials of COVID-19 vaccine

Sanofi and GSK bring proven science and technology to the fight against the global COVID-19 pandemic, with the shared objective of delivering a safe and effective vaccine. ... A week later, Sanofi and GSK forged another agreement with the US government

[ Previous 5 results ] 4 5 6 7 8 9 10 11 12 13 [ Next 5 results ]